{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:38:42Z","timestamp":1786541922688,"version":"build-2736575974"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Long-acting growth hormone (LAGH) formulations represent an important therapeutic advance in the management of growth hormone deficiency (GHD) because they reduce injection frequency and treatment burden and may improve adherence and patient-reported experience. Beyond these established advantages, we propose a hypothesis-generating framework in which motivation- and reward-related neuroendocrine pathways may interact with hypothalamic regulation of the growth hormone (GH) axis. This review summarises current knowledge on the neurobiological interplay among motivation, reward, stress, and GH secretion, with specific relevance to paediatric GHD and LAGH therapy. We discuss the roles of dopaminergic signalling, endogenous opioid systems, hypothalamic control of GH secretion, and the bidirectional interactions between GH and central neural circuits. Because direct clinical evidence in paediatric LAGH-treated populations remains limited, the proposed relationships should be interpreted as biologically plausible but not yet established causal mechanisms. Finally, we outline future translational and clinical studies needed to determine whether motivational state is associated with endocrine responses, treatment experience, or clinical outcomes beyond the well-documented benefit of improved adherence.<\/jats:p>","DOI":"10.3389\/fendo.2026.1804285","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:08:21Z","timestamp":1786540101000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-acting growth hormone therapy in paediatric growth hormone deficiency: reduced treatment burden and unproven motivation-related neuroendocrine effects"],"prefix":"10.3389","volume":"17","author":[{"given":"Rossella","family":"Gaudino","sequence":"first","affiliation":[{"name":"Department of Surgical Science, Dentistry, Gynecology and Paediatrics, Paediatric Unit, Verona University Medical School","place":["Verona, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Antoniazzi","sequence":"additional","affiliation":[{"name":"Department of Surgical Science, Dentistry, Gynecology and Paediatrics, Paediatric Unit, Verona University Medical School","place":["Verona, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zaffanello","sequence":"additional","affiliation":[{"name":"Department of Surgical Science, Dentistry, Gynecology and Paediatrics, Paediatric Unit, Verona University Medical School","place":["Verona, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Pietrobelli","sequence":"additional","affiliation":[{"name":"Department of Surgical Science, Dentistry, Gynecology and Paediatrics, Paediatric Unit, Verona University Medical School","place":["Verona, Italy"]},{"name":"Pennington Biomedical Research Center","place":["Baton Rouge, LA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zoller","sequence":"additional","affiliation":[{"name":"Department of Surgical Science, Dentistry, Gynecology and Paediatrics, Paediatric Unit, Verona University Medical School","place":["Verona, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Lanzafame","sequence":"additional","affiliation":[{"name":"Department of Surgical Science, Dentistry, Gynecology and Paediatrics, Paediatric Unit, Verona University Medical School","place":["Verona, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Piacentini","sequence":"additional","affiliation":[{"name":"Department of Surgical Science, Dentistry, Gynecology and Paediatrics, Paediatric Unit, Verona University Medical School","place":["Verona, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: Growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency","volume":"86","author":"Grimberg","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac117","article-title":"Treatment burden of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: A randomized study","volume":"6","author":"Maniatis","year":"2022","journal-title":"J Endocr Soc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae834","article-title":"Long-acting growth hormone therapy in pediatric growth hormone deficiency: A consensus statement","volume":"110","author":"Maniatis","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2025.06.005","article-title":"Long-acting growth hormone preparations","volume":"54","author":"Yuen","year":"2025","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1520210","article-title":"Discomfort towards peers causes therapy-related stress in children and adolescents on daily rhGH therapy","volume":"16","author":"Corica","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000521074","article-title":"Stress and growth in children and adolescents","volume":"96","author":"Mousikou","year":"2023","journal-title":"Horm Res Paediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.brainresrev.2007.07.014","article-title":"Behavioral functions of the mesolimbic dopaminergic system: An affective neuroethological perspective","volume":"56","author":"Alcaro","year":"2007","journal-title":"Brain Res Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00532-4","article-title":"Stress and the dopaminergic reward system","volume":"52","author":"Baik","year":"2020","journal-title":"Exp Mol Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000318495","article-title":"Neurotransmitter modulation of the GHRH-GH axis","volume":"38","author":"Garc\u00eda-Tornadu","year":"2010","journal-title":"Front Horm Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1741139","article-title":"The role of dopamine release and D2 dopamine receptor in GHRH and somatostatin cells in controlling growth hormone secretion","volume":"16","author":"de Souza","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A typology of reviews: An analysis of 14 review types and associated methodologies","volume":"26","author":"Grant","year":"2009","journal-title":"Health Info Libr J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integr Peer Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-6-1136","article-title":"Role of dopamine in the regulation of growth hormone secretion: Dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man","volume":"64","author":"Vance","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000124760","article-title":"Dual action of dopamine on growth hormone release in vitro","volume":"45","author":"Serri","year":"1987","journal-title":"Neuroendocrinology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.2531-19.2020","article-title":"Tyrosine hydroxylase neurons regulate growth hormone secretion via short-loop negative feedback","volume":"40","author":"Wasinski","year":"2020","journal-title":"J Neurosci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12957","article-title":"Growth hormone receptor in dopaminergic neurones regulates stress-induced prolactin release in male mice","volume":"33","author":"Wasinski","year":"2021","journal-title":"J Neuroendocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09861-x","article-title":"New findings on brain actions of growth hormone and potential clinical implications","volume":"25","author":"Donato","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-025-09943-y","article-title":"Update on regulation of GHRH and its actions on GH secretion in health and disease","volume":"26","author":"Montero-Hidalgo","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1016\/j.cell.2025.05.039","article-title":"Neuroendocrine circuit for sleep-dependent growth hormone release","volume":"188","author":"Ding","year":"2025","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1332114","article-title":"Complex relationship between growth hormone and sleep in children: Insights, discrepancies, and implications","volume":"14","author":"Zaffanello","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.4.8750","article-title":"Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice","volume":"143","author":"D\u00edaz-Torga","year":"2002","journal-title":"Endocrinology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06902","article-title":"GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin","volume":"190","author":"Garc\u00eda-Tornad\u00fa","year":"2006","journal-title":"J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.22.6.0451","article-title":"Dopamine as a prolactin (PRL) inhibitor","volume":"22","author":"Ben-Jonathan","year":"2001","journal-title":"Endocr Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.0129-12.2012","article-title":"Prolactin regulates tuberoinfundibular dopamine neuron discharge pattern: Novel feedback control mechanisms in the lactotrophic axis","volume":"32","author":"Lyons","year":"2012","journal-title":"J Neurosci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.3390\/jcm12175504","article-title":"The impact of growth hormone therapy on sleep-related health outcomes in children with Prader-Willi syndrome: A review and clinical analysis","volume":"12","author":"Zaffanello","year":"2023","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/jci29867","article-title":"Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite","volume":"116","author":"Abizaid","year":"2006","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/1755-7682-3-24","article-title":"Dopaminergic reward system: A short integrative review","volume":"3","author":"Arias-Carri\u00f3n","year":"2010","journal-title":"Int Arch Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.1151-21.2021","article-title":"Complexes of ghrelin GHS-R1a, GHS-R1b, and dopamine D(1) receptors localized in the ventral tegmental area as main mediators of the dopaminergic effects of ghrelin","volume":"42","author":"Navarro","year":"2022","journal-title":"J Neurosci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1804285\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:08:21Z","timestamp":1786540101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1804285\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":28,"alternative-id":["10.3389\/fendo.2026.1804285"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1804285","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1804285"}}